{"disease":{"id":"hypertensive-nephropathy","name":"hypertensive nephropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07187713","title":"ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Ace Cells Lab Limited","has_results":false},{"nct_id":"NCT04633993","title":"Effectiveness of Implementation of a Patient-centered Self-management Program in Patients With Hypertensive Nephropathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"National Taipei University of Nursing and Health Sciences","has_results":false},{"nct_id":"NCT07240987","title":"Mesenchymal Stem Cells for Chronic Kidney Diseases","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"The First Affiliated Hospital of Air Force Medicial University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}